Oslo University Hospital
Meryam Sugelle
The GaP study is designed to close important knowledge gaps by: 1. exploring placental health and cellular ageing in GDM and the association with neonatal outcome 2. evaluating the effectiveness of current and novel maternal health follow-up strategies after GDM
Gestational Diabetes
Cardiovascular Diseases
Placenta Diseases
The incidence of gestational diabetes mellitus (GDM) is increasing. GDM has potential adverse short and long term health effects for both the women and her offspring, and involves dysfunctional interaction between placenta and the maternal body. The burden for the individual, the health system and society warrants further investigations into the placental-maternal crosstalk in GDM in order to improve personalized pregnancy surveillance and follow-up. In Oslo county, nearly twice as many women who give birth suffer from GDM (5.7%) than from preeclampsia (2.3%). The large obstetric department at Ullevål provides an optimal environment for novel translational studies and clinical practical aspects of GDM. The GaP study is designed to close important knowledge gaps by: 1. exploring placental health and cellular ageing in GDM and the association with neonatal outcome 2. evaluating the effectiveness of current and novel maternal health follow-up strategies after GDM
| Study Type : | OBSERVATIONAL |
| Estimated Enrollment : | 350 participants |
| Official Title : | The GaP Study: Gestational Diabetes Mellitus: "Placental-maternal Crosstalk and Future Health |
| Actual Study Start Date : | 2023-06-01 |
| Estimated Primary Completion Date : | 2026-06 |
| Estimated Study Completion Date : | 2026-06 |
Information not available for Arms and Intervention/treatment
| Ages Eligible for Study: | 18 Years |
| Sexes Eligible for Study: | FEMALE |
Want to participate in this study, select a site at your convenience, send yourself email to get contact details and prescreening steps.
Not yet recruiting
Oslo University Hospital
Oslo, Norway, 0407